Tradjenta
Tradjenta

2.19
Used to address diabetes, this generic medicine regulates blood sugar levels by increasing the body's natural insulin production after meals.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Linagliptin
Reference Brand
Linagliptin
Product Origin
Generic Alternative
Reference Manufacturer
Boehringer Ingelheim
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
Pharmacological Class
Antidiabetic
Clinical Indications
Manufacturer Description
Developed to mitigate blood glucose parameters to support long-term metabolic health and target insulin secretion.
Mechanism of Action
Inhibits DPP-4, protecting natural active incretin hormones to stimulate pancreatic insulin release and block glucagon.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Diabetic ketoacidosis, History of severe hypersensitivity to linagliptin
Severe Adverse Events
Acute pancreatitis — requires immediate medical attention, Bullous pemphigoid — requires immediate medical attention
Common Side Effects
Headache, Nasopharyngitis, Diarrhea
Uncommon Side Effects
Joint pain, Hypoglycemia, Mild rash
Drug Interactions
Insulin, Rifampin
Pregnancy Safety Warnings
TGA Category B: Safety verified in animal models. Breastfeeding: Consult a clinician.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Tradjenta is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Sleep Management AU - Melatonin Natural Sleep Aid